Berger Singerman, Florida’s business law firm, is pleased to announce that attorneys and several non-attorney team members of Rocke McLean Sbar (RMS) ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

Fenebrutinib significantly reduced the annualized relapse rate in patients with relapsing multiple sclerosis compared with teriflunomide.

In nine months, the city saw its composting efforts expand from 129 participating households to more than 1,150 homes With that, food waste collections increased by seven times. Launching back on ...

RHHBY's fenebrutinib slashes RMS relapses by 51% in phase III, advancing its bid for a first high-efficacy oral therapy in MS ...

Rigby Middle School eighth grade students took first place at the Idaho Environmental Coalition’s first-ever Ecobots ...

The Swiss drugmaker reported a phase 3 win for fenebrutinib over Sanofi's Aubagio in RMS in November. In that study, Roche linked its drug candidate to a 59% reduction in the annualized relapse rate ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...

A homelessness prevention program that began in California's Santa Clara County is expanding nationwide to help families avoid eviction and stay housed. Nonprofit Destination: Home says it ...

Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and ...

RMS is honored to continue and expand our support to the U.S. Air Force.”— Adrian Brinks, General Manager PANAMA CITY, ...

(AI) 8112 Universal Digital Coupons (UDC) are now accepted across all Thrifty White Health locations DENVER, CO, UNITED STATES, February 2, 2026 / EINPresswire.com / — Thrifty White Pharmacy, nData ...